HC Deb 12 May 2004 vol 421 cc452-3W
Miss Kirkbride

To ask the Secretary of State for Health when the Exubera inhaler will gain a certificate of a medicinal product and become available on the NHS to diabetics. [170535]

Ms Rosie Winterton

As with all marketing authorisation applications, before Exubera is granted a licence and becomes available in the United Kingdom it must be fully evaluated in relation to the appropriate standards required in the relevant European rules and regulations on medicinal products. Data submitted in support of the application will need to demonstrate that the safety, quality and efficacy of the product are satisfactory for its intended use.